Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 15, 2018

SELL
$57.91 - $92.15 $214,846 - $341,876
-3,710 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$45.65 - $59.37 $169,361 - $220,262
3,710
3,710 $218,000

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $232M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track East Coast Asset Management, Llc. Portfolio

Follow East Coast Asset Management, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of East Coast Asset Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on East Coast Asset Management, Llc. with notifications on news.